KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$12000.0.

  • Cardlytics' Cash from Financing Activities rose 9690.72% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.3 million, marking a year-over-year decrease of 41328.22%. This contributed to the annual value of $1.4 million for FY2024, which is 10721.06% up from last year.
  • Cardlytics' Cash from Financing Activities amounted to -$12000.0 in Q3 2025, which was up 9690.72% from -$2.1 million recorded in Q2 2025.
  • Cardlytics' 5-year Cash from Financing Activities high stood at $484.7 million for Q1 2021, and its period low was -$50.1 million during Q2 2023.
  • Its 5-year average for Cash from Financing Activities is $22.2 million, with a median of -$6000.0 in 2022.
  • As far as peak fluctuations go, Cardlytics' Cash from Financing Activities tumbled by 551788.62% in 2022, and later soared by 1637307.69% in 2023.
  • Cardlytics' Cash from Financing Activities (Quarter) stood at $225000.0 in 2021, then tumbled by 179.56% to -$179000.0 in 2022, then soared by 126.82% to $48000.0 in 2023, then plummeted by 520.83% to -$202000.0 in 2024, then soared by 94.06% to -$12000.0 in 2025.
  • Its Cash from Financing Activities was -$12000.0 in Q3 2025, compared to -$2.1 million in Q2 2025 and -$3.0 million in Q1 2025.